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Abstract Recombinant LytB protein from the thermophilic eu-
bacterium Aquifex aeolicus produced in Escherichia coli was
puri¢ed to apparent homogeneity. The puri¢ed LytB protein
catalyzed the reduction of (E)-4-hydroxy-3-methyl-but-2-enyl
diphosphate (HMBPP) in a de¢ned in vitro system. The reac-
tion products were identi¢ed as isopentenyl diphosphate and
dimethylallyl diphosphate. A spectrophotometric assay was
established to determine the steady-state kinetic parameters of
LytB protein. The maximal speci¢c activity of 6.6 * 0.3 Wmol
min31 mg31 protein was determined at pH 7.5 and 60‡C.
The kcat value of the LytB protein was 3.7 * 0.2 s31 and the
Km value for HMBPP was 590* 60 WM.
2 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
In a variety of organisms isoprenoids are synthesized by the
mevalonate-independent 2-C-methyl-D-erythritol-4-phosphate
(MEP) pathway. Although the ¢rst ¢ve enzymatic steps of
this pathway are well characterized only indirect evidence
has been provided so far for two additional enzymes, GcpE
and LytB, being involved in the terminal steps of the reaction
cascade (Kollas et al., this issue). This article reports on the
puri¢cation of LytB protein and analysis of its enzymatic
activity in a de¢ned in vitro system.
2. Materials and methods
2.1. Cloning of the gene encoding LytB protein
The lytB (also named AQ_1739 or ispH) gene of Aquifex aeolicus
(GenBank accession number AE000754) encoding LytB protein was
ampli¢ed by polymerase chain reaction (PCR) using A. aeolicus ge-
nomic DNA (generous gift of Dr. Klaus Reuter, Marburg, Germany)
and the oligonucleotides Aa-LytB-cHis-for (5P-CCATGGTTGACA-
TAATAATCGCA-3P) and Aa-LytB-cHis-rev (5P-AGATCTGGAG-
GAAACCAATTGCCC-3P), introducing an NcoI and BglII restriction
site, respectively. The PCR was performed in a total volume of 20 Wl
using a Stratagene Robocycler with heated lid and the Expand high-
¢delity PCR system (Roche). Conditions used were 30 cycles of de-
naturation at 94‡C for 30 s, annealing at 50‡C for 30 s, and extension
at 72‡C for 60 s, followed by a ¢nal 7 min step at 72‡C to allow
complete extension of the product. The PCR product was ligated into
the pCR-TOPO-T/A-vector (Invitrogen), veri¢ed by restriction endo-
nuclease analysis and sequencing, and subsequently cloned into the
pQE60 vector (Qiagen) using the restriction enzymes NcoI and BglII
resulting in the plasmid pQE60-Aa-LytB. This construct allowed the
production of the A. aeolicus LytB protein (Swiss-Prot accession num-
ber O67625) in Escherichia coli with a carboxy-terminal extension of
eight amino acids (RSHHHHHH).
2.2. Expression and puri¢cation of recombinant LytB protein
XL1-Blue E. coli cells harboring a plasmid encoding tRNAs for
enhanced translation of A/U-rich sequences (Stratagene) were trans-
formed with pQE60-Aa-LytB. Transformants were grown with aera-
tion at 30‡C in 500 ml standard I medium (Merck) supplemented with
ampicillin (150 Wg ml31), chloramphenicol (25 Wg ml31), and FeCl3
(50 Wg ml31). Optimal protein production was observed when cultures
were grown without induction of the lac promotor to an optical den-
sity of 5^6 at 600 nm. The cells were harvested by centrifugation and
cell pellets were stored at 340‡C until use.
All puri¢cation steps were carried out in a Coy glove box under an
atmosphere of N2/H2 (95%/5%) and with dioxygen-free solutions pre-
pared as described [1]. The cell pellet (3.5 g) was resuspended in 50 ml
bu¡er A (30 mM Tris^HCl (pH 8.0), 100 mM NaCl) and disinte-
grated by ultrasonic treatment at 0‡C. After centrifugation of the
cell lysate at 15 000Ug for 20 min at 4‡C the supernatant was incu-
bated at 65‡C for 30 min in a water bath. After centrifugation at
15 000Ug for 30 min at 4‡C the supernatant containing the thermo-
stable A. aeolicus LytB protein was ¢ltrated over a 0.2 Wm ¢lter
(Renner) and imidazole was added to a ¢nal concentration of 10
mM. The hexa-histidine-LytB fusion protein was puri¢ed by immobi-
lized metal a⁄nity chromatography on Talon super£ow resin (BD
Clontech) using a HR 10/10 column (Amersham Pharmacia) and a
Pharmacia fast protein liquid chromatography (FPLC) device. Bu¡ers
used were: A, 30 mM Tris^HCl (pH 8.0), 100 mM NaCl; B, 30 mM
Tris^HCl (pH 8.0), 100 mM NaCl, 100 mM imidazole. Chromatog-
raphy was done with a £ow rate of 2 ml min31 as follows: equilibra-
tion, 30 min 90% A and 10% B; loading of protein solution; washing,
15 min 80% A and 20% B; elution, 15 min 100% B. The eluted LytB
protein (approximately 48 mg) was rebu¡ered and desalted in 20 mM
Tris^HCl (pH 8.0) using a prepacked PD10 Sephadex G-25 gel ¢ltra-
tion column (Amersham Pharmacia). When necessary the protein was
concentrated using ultrafree centrifugal ¢lter devices (Millipore). All
puri¢cation steps were monitored by sodium dodecyl sulfate^polyac-
rylamide gel electrophoresis (SDS^PAGE) analysis. Protein concen-
trations were measured using the method of Bradford with bovine
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serum albumin as standard. The concentration of puri¢ed LytB pro-
tein was determined in 20 mM sodium phosphate bu¡er (pH 6.5)
containing 6 M guanidium hydrochloride by ultraviolet (UV) spec-
troscopy (O280 = 26.0 mM31 cm31). Recombinant LytB protein was
stored at 340‡C until use.
2.3. Assay of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate
(HMBPP) reductase activity of LytB protein and analysis of the
reaction products by high-performance liquid chromatography
(HPLC) and HPLC-electrospray ionization-mass spectrometry
(ESI-MS)
Assays were carried out in a Coy glove box under an atmosphere of
N2/H2 (95%/5%) and with dioxygen-free solutions. The standard assay
system consisted of 20 mM Tris^HCl (pH 7.5), 5 mM HMBPP, 10
mM sodium dithionite, and 3 WM LytB protein in a ¢nal volume of
250 Wl. After incubation for 1 h at 60‡C the analysis was performed
on a 250U2 mm, 13 Wm AS11-HC column (Dionex), and a 50U2 mm
AG11-HC precolumn, using a Dionex DX-600 device equipped with
an electrochemical detector (ED50). Solvents used were: A, 20 mM
KOH; B, 100 mM KOH. Chromatography was done with a £ow rate
of 1 ml min31 as follows: 3 min 90% A and 10% B; linear gradient to
100% B in 30 min; equilibration, 12 min 90% A and 10% B. HPLC-
ESI-MS analysis was performed as described by Kollas et al. (this
issue). Mass peaks were detected by single ion recording in negative
mode [M-H]3 for HMBPP (m/z 261), isopentenyl diphosphate (IPP)
and dimethylallyl diphosphate (DMAPP) (m/z 245).
2.4. Initial velocity assays for LytB protein
All solutions were made dioxygen free before used. To monitor the
activity of LytB protein methyl viologen was used as reductant. The
oxidation of methyl viologen was followed at 732 nm (O732 = 3150 M31
cm31) because the absorbance at absorption maximum (O604 = 13 600
M31 cm31) [2] was too high. Standard assays were performed at 60‡C
in anaerobic gas-tight quartz cuvettes and contained 20 mM Tris^HCl
(pH 7.5), 2 mM methyl viologen, and varying concentrations of
HMBPP (0^2.8 mM) in a total volume of 800 Wl. After reduction of
methyl viologen with sodium dithionite (typically 0.3^0.7 mM) until
an absorbance of 1.57 was reached, corresponding to 0.5 mM reduced
methyl viologen (semiquinone form), the reactions were initiated by
the addition of enzyme. Typically, assays contained 3 WM LytB pro-
tein but concentrations between 0.5 and 6 WM were also tested. Ac-
tivity is expressed as Wmol of HMBPP reduced per min and mg of
protein. It was assumed that two equivalents reduced methyl viologen
are needed to reduce one equivalent HMBPP. Kinetic data were ¢tted
to the standard Michaelis^Menten equations using SigmaPlot 2000
(SPSS Science).
3. Results
For the analysis of LytB protein, the lytB gene from di¡er-
ent organisms was expressed in E. coli. Optimal yields of
recombinant protein were obtained with the lytB gene from
A. aeolicus. The A. aeolicus LytB protein was puri¢ed in two
steps under dioxygen-free conditions. After heat treatment at
65‡C, the thermostable LytB protein was puri¢ed to over 95%
homogeneity by immobilized metal a⁄nity chromatography
(Fig. 1). The protein sample showed a brownish color with
a broad absorption maximum at 420 nm that decreased after
reduction with sodium dithionite, indicating the presence of
an iron^sulfur cluster (Fig. 2). Further analysis of the iron^
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Fig. 1. SDS^PAGE analysis of the puri¢cation of LytB protein.
After heat treatment, LytB protein was puri¢ed from the soluble
fraction by immobilized metal a⁄nity chromatography on Talon
super£ow resin. Lane 1, heat-stable protein fraction; lane 2, £ow
through; lane 3, puri¢ed LytB protein. Molecular mass standards
are indicated in kDa. The migration velocity of the LytB protein is
in accordance with the calculated molecular mass of 33.17 kDa.
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Fig. 2. UV-visible spectra of LytB protein. Puri¢ed LytB showed a
broad absorption maximum at 420 nm that decreased after reduc-
tion with sodium dithionite, indicating the presence of an iron^
sulfur cluster.
Fig. 3. Analysis of the reaction products of LytB protein by anion
exchange HPLC. HMBPP was incubated in absence (control) and
presence of LytB protein (assay) for 1 h at 60‡C with sodium di-
thionite as reductant. IPP and DMAPP were generated in a ratio of
approximately 5:1. Authentic IPP and DMAPP were used as stan-
dards. The peak marked with an asterisk resulted from sodium di-
thionite.
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sulfur cluster was performed by EPR and Raman spectrosco-
py and will be reported in due course.
Incubation of LytB protein and HMBPP in a de¢ned assay
mixture with dithionite as reductant resulted in consumption
of HMBPP and formation of IPP and DMAPP, in a ratio of
approximately 5:1, as estimated by anion exchange HPLC
(Fig. 3). No reaction was observed in a control sample with-
out enzyme. Additionally, mass peaks of HMBPP, IPP and
DMAPP were recorded by anion exchange HPLC-ESI-MS
(Fig. 4). In order to quantify the ratio of IPP to DMAPP
produced by the enzymatic reaction more precisely, de¢ned
mixtures of authentic IPP and DMAPP in di¡erent ratios
were analyzed in parallel. Again, the ratio of IPP to DMAPP
produced by the lytB protein-catalyzed reaction was in a
range between 4:1 and 5:1 (Fig. 4).
For the determination of the kinetic parameters of LytB
protein, a spectrophotometric assay was established. The pH
optimum of LytB protein was in a range of pH 7.0^7.5. The
e¡ect of temperature on the enzyme activity was investigated
over a range of 30^70‡C. Maximal activity was observed at
60‡C (Fig. 5). The activation energy was estimated to be
49T 2 kJ mol31 based on an Arrhenius plot (Fig. 5, inset).
The Km value for HMBPP of 590T 60 WM was calculated
based on a Michaelis^Menten plot (Fig. 6). The speci¢c ac-
tivity was 6.6 T 0.3 Wmol min31 mg31 protein corresponding
to a kcat value of 3.7 T 0.2 s31 for LytB protein. The enzyme
retained more than 95% of the activity after freezing at 320‡C
in 20 mM Tris^HCl (pH 8.0) for 2 weeks. However, it was
highly sensitive to dioxygen. After incubation at air for 10
min only 21% of the activity was retained.
4. Discussion
The value of the speci¢c activity of LytB protein deter-
mined in the present study is over 3000 times higher than
previously reported for E. coli LytB protein (approximately
2 nmol min31 mg31 protein), which was puri¢ed without ex-
clusion of dioxygen and assayed in a crude E. coli cell extract
based on conversion of radioactively labeled HMBPP [3].
Under our assay conditions, the formation of IPP and
DMAPP in a ratio of approximately 5:1 was observed. A
similar ratio was previously reported when the synthesis of
IPP and DMAPP from 13C-labeled 1-deoxy-D-xylulose was
studied in E. coli cells overexpressing several genes of the
MEP pathway [4]. The formation of IPP and DMAPP by a
single enzyme is in striking contrast to the mevalonate path-
way where DMAPP is successively synthesized from IPP by
IPP isomerase. Branching of the MEP pathway for the for-
mation of IPP and DMAPP has already been suggested earlier
based on isotope labeling experiments [5] and the fact that
E. coli deletion mutants for IPP isomerase are viable [6]. Elu-
cidation of the catalytic mechanism of LytB protein for this
unusual formation of two products from one substrate re-
mains the subject of future studies. A hypothetical mechanism
may include the elimination of the hydroxyl group leading to
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Fig. 4. Analysis of the reaction products of LytB protein by anion
exchange HPLC-ESI-MS. Assay mixtures in absence (control) and
presence of LytB protein (assay) were analyzed and compared to
mixtures of authentic IPP and DMAPP in order to estimate the ra-
tio of produced IPP to DMAPP.
Temperature (°C)
20 30 40 50 60 70 80
V
 (
µ
m
o
l 
m
in
-1
 m
g
-1
)
0
1
2
3
4
1/T (x10-3)
2,9 3,1 3,2 3,4
ln
 V
-0,5
0,5
1,5
Fig. 5. Temperature dependence of LytB protein activity. The e¡ect
of temperature on LytB protein activity was investigated over a
range of 30^70‡C. The inset shows the Arrhenius plot used to esti-
mate the activation energy. All data are average values of at least
duplicate determinations.
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Fig. 6. Michaelis^Menten plot of LytB protein activity. HMBPP
concentrations were varied from 0 to 2.8 mM and the respective ini-
tial velocities determined. The Km value for HMBPP was 590T60
WM. The inset shows the Lineweaver^Burk plot.
FEBS 26819 4-12-02
B. Altincicek et al./FEBS Letters 532 (2002) 437^440 439
a resonance stabilized allyl cation, which is reduced to the
allyl anion and protonated either at carbon 1 or 3 (Fig. 7).
It was shown by Kollas et al. (this issue) that also the gcpE
gene product is enzymatically active in converting 2-C-methyl-
D-erythritol-2,4-cyclodiphosphate into HMBPP with dithio-
nite as arti¢cial electron donor without the need for any addi-
tional protein factors. Therefore, the complete MEP pathway
must be considered as proven. Since it is absent in humans,
the MEP pathway provides an attractive target for the devel-
opment of novel antimicrobial and herbicidal agents. Previ-
ously, the natural antibiotic fosmidomycin was shown to be
an inhibitor of 1-deoxy-D-xylulose-5-phosphate reductoiso-
merase [7^9], the second enzyme of the MEP pathway, and
proved to be e⁄cient in curing urogenital tract infections and
malaria in a number of clinical studies [10,11]. Similar to
1-deoxy-D-xylulose-5-phosphate reductoisomerase, GcpE and
LytB represent highly conserved enzymes without any homol-
ogies to mammalian enzymes. Consequently, broad spectrum
activity without mechanism-based toxicity to humans can be
expected from speci¢c inhibitors. For the development of such
inhibitors, the data presented are of considerable relevance. In
particular, the convenient photometric assay may be useful for
testing a larger numbers of candidate compounds. Also, solv-
ing the crystal structures of GcpE and LytB may now be
achievable, taking their sensitivity to dioxygen into account.
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Fig. 7. Hypothetical reaction mechanism for the conversion of HMBPP into IPP and DMAPP by LytB protein.
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